KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT.

A Jethanandani, NA Hanson, I Ogobuiro, G Simpson… - 2024 - ascopubs.org
709 Background: Stereotactic body radiotherapy (SBRT) has been incorporated into multi-
modality treatment of locally advanced and borderline resectable pancreatic ductal …
相关文章

KRAS mutation status in the prediction of pancreatic tumor response after neoadjuvant systemic therapy and magnetic resonance-guided SBRT

A Jethanandani, NA Hanson… - Journal of clinical …, 2024 - scholarship.miami.edu
709 Background: Stereotactic body radiotherapy (SBRT) has been incorporated into multi-
modality treatment of locally advanced and borderline resectable pancreatic ductal …